| Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation F Perner, C Perner, T Ernst, FH Heidel Cells 8 (8), 854, 2019 | 162 | 2019 |
| Substance P release by sensory neurons triggers dendritic cell migration and initiates the type-2 immune response to allergens C Perner, CH Flayer, X Zhu, PA Aderhold, ZNA Dewan, T Voisin, ... Immunity 53 (5), 1063-1077. e7, 2020 | 153 | 2020 |
| Time-dependent changes in microglia transcriptional networks following traumatic brain injury S Izzy, Q Liu, Z Fang, S Lule, L Wu, JY Chung, A Sarro-Schwartz, ... Frontiers in cellular neuroscience 13, 307, 2019 | 75 | 2019 |
| The CysLT2R receptor mediates leukotriene C4-driven acute and chronic itch T Voisin, C Perner, MA Messou, S Shiers, S Ualiyeva, Y Kanaoka, ... Proceedings of the National Academy of Sciences 118 (13), e2022087118, 2021 | 62 | 2021 |
| Disease specific aspects of malnutrition in neurogeriatric patients T Prell, C Perner Frontiers in aging neuroscience 10, 80, 2018 | 46 | 2018 |
| Plasma VCAM1 levels correlate with disease severity in Parkinson’s disease C Perner, F Perner, N Gaur, S Zimmermann, OW Witte, FH Heidel, ... Journal of neuroinflammation 16, 1-5, 2019 | 37 | 2019 |
| The chitinases as biomarkers for amyotrophic lateral sclerosis: signals from the CNS and beyond N Gaur, C Perner, OW Witte, J Grosskreutz Frontiers in Neurology 11, 377, 2020 | 29 | 2020 |
| Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function F Perner, TM Schnöder, S Ranjan, D Wolleschak, C Ebert, MC Pils, S Frey, ... Leukemia 30 (4), 991-995, 2016 | 26 | 2016 |
| Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients C Perner, F Perner, B Stubendorff, M Förster, OW Witte, FH Heidel, T Prell, ... Journal of neuroinflammation 15 (1), 1-5, 2018 | 24 | 2018 |
| Protocol for dissection and culture of murine dorsal root ganglia neurons to study neuropeptide release C Perner, CL Sokol STAR protocols 2 (1), 100333, 2021 | 23 | 2021 |
| Comparison of anonymous versus nonanonymous responses to a medication adherence questionnaire in patients with Parkinson’s disease T Prell, D Schaller, C Perner, GH Franke, OW Witte, A Kunze, ... Patient preference and adherence, 151-155, 2019 | 17 | 2019 |
| Expression and function of ABC-transporter protein ABCB1 correlates with inhibitory capacity of Ruxolitinib in vitro and in vivo C Ebert, F Perner, D Wolleschak, TM Schnöder, T Fischer, FH Heidel haematologica 101 (3), e81, 2016 | 16 | 2016 |
| A decision tree model for neuroimmune guidance of allergic immunity CH Flayer, C Perner, CL Sokol Immunology and Cell Biology 99 (9), 936-948, 2021 | 15 | 2021 |
| Endoplasmic reticulum stress and its role in homeostasis and immunity of central and peripheral neurons C Perner, E Krüger Frontiers in Immunology 13, 859703, 2022 | 13 | 2022 |
| Sicca symptoms in Parkinson’s disease: association with other nonmotor symptoms and health-related quality of life T Prell, D Schaller, C Perner, OW Witte, J Grosskreutz Parkinson’s Disease 2020, 2020 | 10 | 2020 |
| Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic DM DuBreuil, X Lai, K Zhu, G Chahyadinata, C Perner, BM Chiang, ... Molecular Pain 19, 17448069221148351, 2023 | 4 | 2023 |
| Einfluss von ABC-Transportern auf die Sensitivität von T-Zellen gegenüber dem Janus-Kinase-Inhibitor Ruxolitinib C Ebert Otto-von-Guericke-Universität Magdeburg, 2016 | | 2016 |
